http://orcid.org/0000-0002-0093-3236
About the Authors
- Abby Hill
-
Roles Formal analysis, Visualization, Writing – original draft, Writing – review & editing
Current address: Rare Disease Research Unit, Pfizer, Cambridge, Massachusetts, United States of America
Affiliation Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
- Scott Gleim
-
Roles Investigation, Software, Writing – review & editing
Affiliation Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
- Florian Kiefer
-
Roles Data curation, Resources, Software, Writing – review & editing
Affiliation Novartis Informatics, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Frederic Sigoillot
-
Roles Data curation, Investigation, Writing – review & editing
Affiliation Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
- Joseph Loureiro
-
Roles Funding acquisition, Investigation, Writing – review & editing
Affiliation Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
- Jeremy Jenkins
-
Roles Funding acquisition, Investigation, Project administration, Resources, Writing – review & editing
Affiliation Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
- Melody K. Morris
-
Roles Conceptualization, Formal analysis, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: melody.morris@novartis.com
Affiliation Respiratory Disease Area Department, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: All authors were employed by Novartis when the work was completed, and some have equity interest in Novartis. AH is currently employed by Pfizer.